EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Pulmonary and ocular aspergillosis with reduced susceptibility to amphotericin B: A Malaysian case series

Xue Ting Tan, Yii Ling Liow, Nurulyumni Faraha Md Sharizam, Aishah Nazir Deen, Wei Xuan Tuang, Gayathri Govindasamy

IDCases · 2026 · 46 · e02790

DOI: 10.1016/j.idcr.2026.e02790 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IDCases, 2026. Verfasst von Xue Ting Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriology Unit, Infectious Disease Research Centre, National Institute of Health, Ministry of Health Malaysia, Selangor, Malaysia. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated amphotericin B (AmB) minimum inhibitory concentrations (MICs) in Aspergillus spp. may compromise empirical therapy. We describe three aspergillosis cases caused by distinct species with AmB MICs >16 µg/mL. Case presentations: The first case involved postoperative invasive pulmonary aspergillosis due to A. fumigatus. Conventional AmB was used initially because renal impairment and bowel ischaemia limited voriconazole use; the patient later died with multiorgan failure, invasive aspergillosis and nosocomial infections. The second case involved traumatic A. flavus keratitis with newly diagnosed diabetes mellitus. The ocular infection resolved after voriconazole-based therapy and therapeutic keratoplasty, but graft failure and severe visual impairment persisted. The third case involved an infected corneal hydrops with exogenous endophthalmitis due to A. versicolor complex. Despite keratoplasty, vitrectomy and voriconazole-based therapy, the eye progressed to phthisis bulbi.

Conclusions

These cases highlight clinically diverse aspergillosis with elevated AmB MICs, supporting early species identification, timely antifungal susceptibility testing and access to active antifungal therapy.

Schlagwörter

Stichwörter der Autor:innen

Antifungal susceptibility testingAspergillus flavusAspergillus fumigatusAspergillus versicolorMalaysiaOcular

Autor:innen und Institutionen

  • Bacteriology Unit, Infectious Disease Research Centre, National Institute of Health, Ministry of Health Malaysia, Selangor, Malaysia.
  • Unit Microbiology, Department of Pathology, Hospital Sultanah Aminah, Ministry of Health Malaysia, Johor, Malaysia.
  • Clinical Research Centre Unit, Hospital Sultanah Aminah, Ministry of Health Malaysia, Johor, Malaysia.
  • Infectious Disease Unit, Department of Medicine, Hospital Sultanah Aminah, Ministry of Health, Johor, Malaysia.
  • Ophthalmology Department, Hospital Sultanah Aminah, Ministry of Health Malaysia, Johor, Malaysia.

Zitieren

APA

Tan, X. T., Liow, Y. L., Md Sharizam, N. F., Nazir Deen, A., Tuang, W. X., & Govindasamy, G. (2026). Pulmonary and ocular aspergillosis with reduced susceptibility to amphotericin B: A Malaysian case series. IDCases, 46, e02790. https://doi.org/10.1016/j.idcr.2026.e02790

Vancouver

Tan XT, Liow YL, Md Sharizam NF, Nazir Deen A, Tuang WX, Govindasamy G. Pulmonary and ocular aspergillosis with reduced susceptibility to amphotericin B: A Malaysian case series. IDCases. 2026;46:e02790. doi:10.1016/j.idcr.2026.e02790

BibTeX
@article{Tan2026,
  author = {Tan, Xue Ting and Liow, Yii Ling and Md Sharizam, Nurulyumni Faraha and Nazir Deen, Aishah and Tuang, Wei Xuan and Govindasamy, Gayathri},
  title = {Pulmonary and ocular aspergillosis with reduced susceptibility to amphotericin B: A Malaysian case series},
  journal = {IDCases},
  year = {2026},
  volume = {46},
  pages = {e02790},
  doi = {10.1016/j.idcr.2026.e02790}
}
Kostenlos starten →